Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
- 1
- 2
Unipolar Depression | Disease Landscape & Forecast | Major Depressive Disorder | G7 | 2022
The unipolar depression therapy market is crowded and highly genericized. The prominent use of drugs such as selective serotonin reuptake inhibitors (SSRIs) as early-line treatments contributes to…
Major Depressive Disorder | Treatment Algorithms | Claims Data Analysis | US | 2021
Treatment for major depressive disorder (MDD) involves a range of safe and effective therapies, many of which are available as inexpensive generics. Agents for treating MDD span multiple drug…
Unipolar Depression | Access and Reimbursement | Major Depressive Disorder | US | 2019
Numerous drugs from multiple drug classes are used as monotherapies and/or adjunctive therapies for the treatment of major depressive disorder (MDD). The MDD treatment armamentarium is becoming…
Major Depressive Disorder | Treatment Algorithms | Claims Data Analysis | US | 2019
In the United States a plethora of pharmacological treatments from an array of drug classes are available to patients with major depressive disorder (MDD), a highly drug-treated condition. Though…
- 1
- 2
